Optimal timing for intravascular administration set replacement

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 9, 2013, Pages

  Ullman, Amanda J ^a   Cooke, Marie L ^a   Gillies, Donna ^b   Marsh, Nicole M ^c   Daud, Azlina ^a   Mcgrail, Matthew R ^d   O'Riordan, Elizabeth ^e   Rickard, Claire M ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b CUMBERLAND HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d UNIVERSITY OF BALLARAT   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID EMULSION; LIPID;

ADULT; BACTEREMIA; BLOOD; BLOODSTREAM INFECTION; CATHETER INFECTION; CRYSTALLOID; DEATH; EVIDENCE BASED MEDICINE; FUNGEMIA; HUMAN; INFECTION; INFECTION RISK; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MICROBIAL COLONIZATION; NEWBORN; NEWBORN MORTALITY; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; DEVICE REMOVAL; DEVICES; INDWELLING CATHETER; MORTALITY; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME; UTILIZATION; EQUIPMENT; STANDARD; STATISTICS; UTILIZATION REVIEW;

ADULT; BACTEREMIA; BLOOD; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DEVICE REMOVAL; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; LIPIDS; PARENTERAL NUTRITION; TIME FACTORS;

EID: 84898734197     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003588.pub3     Document Type: Review

References (57)

1. Blight I, Amadio J, Thomas P, Wilkinson I, Lusis I. Randomised prospective study of replacing intravenous administration sets at 72 hours versus 120 hour intervals in central venous catheters. 4th Nursing Practice Conference Book of Abstracts. Adelaide, Australia: Flinders University, 1998:3.
2. Buxton AE, Highsmith AK, Garner JS, West CM, Stamm WE, Dixon RE, et al.Contamination of intravenous infusion fluid: effects of changing administration sets. Annals of Internal Medicine 1979;90(5):764-8. [MEDLINE: 373560]
3. Covey M, McLane C, Smith N, Matasic J, Holm K. Infection related to intravascular pressure monitoring: effects of flush and tubing changes. American Journal of Infection Control 1988;16(5):206-13. [PUBMED: 3195780]
4. deMoissac D, Jensen L. Changing IV administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer?. Oncology Nursing Forum 1998;25(5):907-13. [MEDLINE: 9644707]
5. Fox M, Molesky M, Van Aerde JE, Muttitt S. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants. Canadian Journal of Gastroenterology 1999;13(2):147-51. [MEDLINE: 10203434]
6. Gorbea HF, Snydman DR, Delaney A, Stockman J, Martin WJ. Intravenous tubing with burettes can be safely changed at 48-hour intervals. JAMA 1984;251(16):2112-5. [MEDLINE: 6708261]
7. Jakobsen CJ, Grabe N, Nielsen E, Hojbjerg T, Damm M, Lorentzen K, et al.Contamination of intravenous infusion systemsthe effect of changing administration sets. Journal of Hospital Infection 1986;8(3):217-23. [MEDLINE: 2878025]
8. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infection Control 1985;6(9):367-70. [MEDLINE: 3932250]
9. Luskin R, Weinstein R, Nathan C, Chamberlin W, Sherwin A. Extended use of disposable pressure transducers. Journal of the American Medical Association 1986;255(7):916-21. [PUBMED: 3944997]
10. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987;258(13):1777-81. [MEDLINE: 3114506]
11. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72-hour intervals: 72 hours is safe and cost-effective. CINA: Official Journal of the Canadian Intravenous Nurses Association 1990;6(4):12-6.
12. Matlow AG, Kitai I, Kirpalani H, Chapman NH, Corey M, Perlman M, et al.A randomised trial of 72 versus 24 hour intravenous tubing set changes in newborns receiving lipid therapy. Infection Control and Hospital Epidemiology 1999;20(7):487-93. [MEDLINE: 10432161]
13. McLane C, Morris L, Holm K. A comparison of intravascular pressure monitoring system contamination and patient bacteremia with use of 48-and 72-hour system change intervals. Heart and Lung May/June 1998;27(3):200-8. [PUBMED: 9622407]
14. Raad I, Hanna H, Richardson D, Abi-Saia D, Awad A, Alrahwan A, et al.Optimal frequency of changing intravenous administration sets (IVAS): is it safe to prolong duration of use beyond three days?. Infection Control and Hospital Epidemiology 1998;19(Suppl 9):682.
15. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, et al.Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?. Infection Control and Hospital Epidemiology 2001;22(3):136-9. [PUBMED: 11310690]
16. Rickard CM, Lipman J, Courtney M, Siversen R, Daley P. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters. Infection Control and Hospital Epidemiology 2004;25(8):650-5. [PUBMED: 15357156]
17. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1985;9(3):322-5. [MEDLINE: 3925176]
18. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infection Control 1987;8(3):113-6. [MEDLINE: 3646182]
19. Alothman A, Scharf S, Bryce EA. Extending central venous catheter tubing changes to five days: safety and cost effectiveness. Program and Abstracts of the IDSA 34th Annual Meeting. Arlington, Virginia: Infectious Diseases Society of America, 1996:861.
20. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Annals of Internal Medicine 1979;91(2):173-8. [MEDLINE: 111593]
21. Chen Y, Lin M, Lin MY, Wang FD, Liu JH, Chang MS. The central venous tubing change associated with catheter-related infection. Infection Control and Hospital Epidemiology 2000;21(2):94.
22. Cohen DM. A replication study: analysis of bacterial contamination of intravenous administration sets in use for 72 hours. Journal of the New York State Nurses Association 1989;20(3):12. [MEDLINE: 2778552]
23. Franceschi D, Gerding RL, Phillips G, Fratianne RB. RIsk factors associated with intravascular catheter infections in burned patients: a prospective, randomized study. The Journal of Trauma 1989;29(6):811-6. [PUBMED: 2738979]
24. O'Malley M, Shame F, Cera F, McComb R. Value of routine pressure monitoring system changes after 72 hours of continuous use. Critical Care Medicine 1994;22(9):1424-30. [PUBMED: 8062565]
25. Powell CR, Traetow MJ, Fabri PJ, Kudsk KA, Ruberg RL. Op-Site dressing study: a prospective randomized study evaluating povidone iodine ointment and extension set changes with 7-day Op-Site dressings applied to total parenteral nutrition subclavian sites. Journal of Parenteral and Enteral Nutrition 1985;9(4):443-6. [MEDLINE: 3928918]
26. Robathan G, Woodger S, Merante D. A prospective study evaluating the effects of extending total parenteral nutrition line changes to 72 hours. Journal of Intravenous Nursing 1995;18(2):84-7. [MEDLINE: 7707174]
27. Robertson J. Changing central venous catheter lines: evaluation of a modification to clinical practice. Journal of Pediatric Oncology Nursing. 1991;8(4):173-9. [MEDLINE: 1930810]
28. Trautmann M, Zauser B, Wiedeck H, Buttenschon K, Marre R. Bacterial colonization and endotoxin contamination of intravenous infusion fluids. Journal of Hospital Infection 1997;37(3):225-36. [MEDLINE: 9421774]
29. Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. American Journal of Infection Control 2012;40:227-32.
30. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian study on intravascular catheter associated sepsis. The Medical Journal of Australia 1994;161(6):374-8.
31. Crump JA, Collignon PJ. Intravascular catheter-associated infections. European Journal of Clinical Microbiology and Infectious Diseases 2000;19:1-8.
32. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPF, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
33. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
34. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. Journal of Parenteral and Enteral Nutrition 1986;10(5):494-7.
35. Higgins JPT, Altman DG, Stern JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
36. Ishizuka M, Nagata H, Takagi K, Kubota K. Total parenteral nutrition is a major risk factor for central venous catheter-related bloodstream infection in colorectal cancer patients receiving postoperative chemotherapy. European Surgical Research 2008;41(4):341-5.
37. Lefebvre C, Manheimer E, Glanville F. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John Wiley & Sons, 2011.
38. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ionnidis JPA, et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
39. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006;81(9):1159-71.
40. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady N, et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009;49:1-45.
41. Moro ML, Vigano EF, Cozzi Lepri A. Risk factors for central venous catheter-related infections in surgical and intensive care units. Infection Control and Hospital Epidemiology 1994;15(4):253-64.
42. Mulloy RH, Jadavji T, Russell ML. Tunneled central venous catheter sepsis: risk factors in a pediatric hospital. Journal of Parenteral and Enteral Nutrition 1991;15(4):460-3.
43. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al.Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report 2002;51([RR-10]):1-29.
44. O'Grady N, Alexander M, Burns L, Dellinger E, Garland J, et al.and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clinical Journal of Infectious Diseases 2011 May;52(9):1087-99.
45. Pearson ML. Special communication. HICPAC guideline for prevention of intravascular device-related infections. Parts I and II. American Journal of Infection Control 1996;24(4):262-93.
46. Perlman SE, Saiman L, Larson EL. Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. American Journal of Infection Control 2007;35(3):177-82.
47. Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. American Journal of Respiratory and Critical Care Medicine 2001;163(7):1584-90. [MEDLINE: 11401878]
48. The Cochrane Collaboration. Review Manager (RevMan). 5.1 for Windows. Oxford, England: The Cochrane Collaboration, 2012.
49. Rickard C, Daley P, Lipman J, Davie A, Koroloff N, Siversen R, et al.Routine administration set changes do not reduce central venous catheter infection (abstract). Anaesthesia and Intensive Care 2001;29(2):185.
50. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine 2010;152:726-32.
51. Schunemann JH, Oxman AD, Higgins JPF, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
52. Scott EM, Gorman SP, Wyatt TD, Magill EA. Growth of microorganisms in total parenteral nutrition mixtures and related clinical observations. Journal of Clinical and Hospital Pharmacy 1985;10(1):79-88. [MEDLINE: 3923044]
53. Sherertz RJ, Gledhill KS, Hampton KD, Pfaller MA, Givner LB, Abramson JS, et al.Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. Journal of Pediatrics 1992;120(3):455-61. [MEDLINE: 1538298]
54. Shiro H, Muller E, Takeda S, Tosteson TD, Goldmann DA, Pier GB. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. Journal of Infectious Diseases 1995;171(1):220-4. [MEDLINE: 7798668]
55. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infection Control and Hospital Epidemiology 1999;20(6):396-401. [MEDLINE: 10395140]
56. Gillies D, O'Riordan L, Wallen M, Rankin K, Morrison A, Nagy S. Timing of intravenous administration set changes: a systematic review. Infection Control and Hospital Epidemiology 2004;25(3):240-50. [MEDLINE: PMID: 15061417]
57. Gillies D, Wallen MA, Morrison AL, Rankin K, Nagy SA, O'Riordan E. Optimal timing for intravenous administration set replacement. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003588.pub2]